Fund Holdings — Aisling Capital Management LP

Total Portfolio Value
$231.05M
Total Bought
$1.39M
Total Sold
$2.24M
Net Transaction
-$854.1K
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Tectonic Therapeutic Inc (TECX)(TECX)084,148+84,14801,3860.60%+1,386
Marker Therapeutics, Inc. (MRKR)(MRKR)314,286314,28601,3511,7070.74%+355
Aclaris Therapeutics Inc (ACRS)(ACRS)434,455434,45505394780.21%-61
CalciMedica, Inc. (CALC)(CALC)521,114521,11402,1682,0640.89%-104
Reneo Pharmaceuticals Inc (RPHM)886,075886,07501,4711,3380.58%-133
Viracta Therapeutics Inc (VIRX)288,571288,57102941570.07%-137
Poseida Therapeutics Inc. (PSTX)1,043,2671,043,26703,3283,0461.32%-282
Spruce Biosciences, Inc. (SPRB)1,205,5110-1,205,5119480—-948
Avrobio, Inc. (AVRO)1,009,7790-1,009,7791,2930—-1,293
Verona Pharma plc (VRNA)1,115,3521,115,352017,94616,1286.98%-1,818
Nuvation Bio Inc. (NUVB)(NUVB)2,541,0092,541,00909,2497,4203.21%-1,830
Compass Pathways Plc (CMPS)(CMPS)964,500964,50008,0255,8262.52%-2,199
Syndax Pharmaceuticals, Inc. (SNDX)(SNDX)1,025,0001,025,000024,39521,0439.11%-3,352
Monte Rosa Therapeutics Inc (GLUE)(GLUE)1,472,3311,472,331010,3805,5072.38%-4,873
Elevation Oncology Inc (ELEV)2,834,9102,834,910014,5437,6543.31%-6,889
Biomea Fusion Inc (BMEA)(BMEA)798,757798,757011,9413,5941.56%-8,347
BridgeBio Pharma Inc. (BBIO)(BBIO)6,068,1256,068,1250187,626153,70666.52%-33,921
Page 1 of 1
Aisling Capital Management LP — 13F Holdings — Q2 2024 | TickerTrail